-- Alterity Therapeutics（ASX：ATH）周一向澳大利亚证券交易所提交的文件显示，该公司在与美国食品药品监督管理局（FDA）举行的第二次C类会议上获得了积极的反馈，该会议旨在讨论其用于治疗多系统萎缩症（MSA）的候选药物ATH434的三期临床试验计划。 MSA是一种进行性神经退行性疾病，会影响自主神经和运动功能，目前尚无获批的疾病修饰疗法。 该文件还补充道，美国FDA就该项目的化学、生产和控制方面提供了支持性的书面反馈，补充了此前在另一次C类会议上就临床药理学和非临床开发方面提供的指导意见。
Related Articles
Asia
Hong Kong Stocks Edge Lower as U.S.-Iran Talks Stall; CITIC Securities Gains on Profit Jump
Hong Kong stocks ended little changed Monday as U.S.-Iran talks stalled, heightening concerns over potential disruptions to energy flows.The Hang Seng Index fell 52.42 points to end marginally lower at 25,925.65, while the Hang Seng China Enterprises Index dropped 19.30 points to 8,756.32.U.S. President Donald Trump scrapped plans to send envoys to Islamabad for weekend talks, signaling a pause in diplomatic efforts.He said Sunday Iran could call if it wants to negotiate an end to the conflict, while insisting it must not possess nuclear weapons, after Tehran urged the removal of obstacles to a deal, including the U.S. blockade of its ports.Sentiment was partially supported after an Axios report said Iran may prioritize reopening the strait while postponing nuclear negotiations.Meanwhile, China's industrial profits accelerated in March, marking their fastest growth in six months.Profits rose 15.8% year on year, up from a 15.2% increase in the January-February period, according to data from the National Bureau of Statistics released Monday.In corporate news, CITIC Securities (HKG:6030, SHA:600030) closed nearly 2% higher after reporting a 55% growth in first-quarter profit.
$^HSI$HKG:6030$SHA:600030
Asia
WuXi AppTec's Q1 Profit Up 27%
WuXi AppTec (HKG:2359) booked 4.65 billion yuan in attributable profit for the first quarter of 2026, up 27% from 3.67 billion yuan a year earlier, according to a Hong Kong bourse filing Monday.Earnings per share were 1.58 yuan, compared with 1.28 yuan in the prior year.Revenue jumped 29% year on year to 12.44 billion yuan, figures showed.
$HKG:2359
Asia
Care Health Insurance CEO Steps Down
Religare Enterprises (NSE:RELIGARE, BOM:532915) said the managing director and chief executive officer of its subsidiary, Care Health Insurance, has stepped down from the role on April 25 upon completion of tenure, according to an Indian bourse filing on Sunday.Shares of the company rose nearly 2% in Monday's trade.
$BOM:532915$NSE:RELIGARE